| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2025 | Oct 28, 2025 | Viking Therapeutics, Inc. | Director | Sell | 42.5 | - | 0.00% | ✗ | $2.1M |
| Dec 1, 2023 | Dec 5, 2023 | Generation Bio Co. | Director | Buy | 97.5 | +342,960 | 178.81% | ✗ | $477.8K |
| May 16, 2023 | May 18, 2023 | Viking Therapeutics, Inc. | Director | Sell | 5.0 | -40,000 | -57.14% | ✓ | $1M |
| Sep 19, 2022 | Sep 20, 2022 | Generation Bio Co. | Director | Buy | 90.0 | +15,750 | 8.95% | ✗ | $82.8K |
| Sep 15, 2022 | Sep 19, 2022 | Generation Bio Co. | Director | Buy | 97.5 | +50,628 | 40.37% | ✗ | $276.2K |
| Sep 13, 2022 | Sep 15, 2022 | Generation Bio Co. | Director | Buy | 95.0 | +24,384 | 24.13% | ✗ | $127.4K |
| Jan 11, 2021 | Jan 13, 2021 | Generation Bio Co. | Director | Buy | 97.5 | +20,408 | 25.31% | ✗ | $500K |
| Jun 16, 2020 | Jun 18, 2020 | Generation Bio Co. | Director | Buy | 97.5 | +30,000 | 59.26% | ✗ | $570K |
| May 29, 2018 | May 31, 2018 | Viking Therapeutics, Inc. | Director | Buy | 95.0 | +30,000 | 100.00% | ✗ | $154.8K |